{"pmid":32362468,"title":"Cancer surgery in a time of COVID-19: Many questions, few certainties.","text":["Cancer surgery in a time of COVID-19: Many questions, few certainties.","Eur J Surg Oncol","Ghignone, F","Mohan, H M","Montroni, I","32362468"],"journal":"Eur J Surg Oncol","authors":["Ghignone, F","Mohan, H M","Montroni, I"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362468","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ejso.2020.04.046","keywords":["covid-19","cancer care","evidence-based standards","surgical oncology"],"topics":["Prevention"],"weight":1,"_version_":1666138496023134208,"score":9.490897,"similar":[{"pmid":32312591,"pmcid":"PMC7158818","title":"Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology.","text":["Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology.","Eur J Surg Oncol","Marano, Luigi","Marrelli, Daniele","Roviello, Franco","32312591"],"journal":"Eur J Surg Oncol","authors":["Marano, Luigi","Marrelli, Daniele","Roviello, Franco"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312591","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ejso.2020.04.004","keywords":["covid-19","cancer care","coronavirus","surgical oncology"],"locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666138493527523330,"score":114.03467},{"pmid":32380501,"title":"Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg.","text":["Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg.","With the outbreak of the COVID-19 pandemia, routine clinical work was immediately, deeply, and sustainably impacted in Germany and worldwide. The infrastructure of almost all hospitals is currently redirected to provide a maximum of intensive care resources, including the necessary staff. In parallel, routine as well as emergency clinical care for all patients in need has to be secured. This challenge becomes particularly evident in cancer care. In order to maintain adequate oncological care at all levels of provision and to conduct especially curative and intensive treatments with a maximum of safety, continuous adaption of the oncology care system has to be ensured. Intensive communication with colleagues and patients is needed as is consequent expert networking and continuous reflection of the own developed strategies. In parallel, it is of high importance to actively avoid cessation of innovation in order not to endanger the continuous improvement in prognosis of cancer patients. This includes sustained conduction of clinical trials as well as ongoing translational research. Here, we describe measures taken at the University Cancer Center Hamburg (UCCH) - a recognized comprehensive oncology center of excellence - during the COVID-19 crisis. We aim to provide support and potential perspectives to generate a discussion basis on how to maintain high-end cancer care during such a crisis and how to conduct patients safely into the future.","Oncol Res Treat","Weisel, Katja C","Morgner-Miehlke, Andrea","Petersen, Cordula","Fiedler, Walter","Block, Andreas","Schafhausen, Philippe","Knobloch, Johannes K","Bokemeyer, Carsten","32380501"],"abstract":["With the outbreak of the COVID-19 pandemia, routine clinical work was immediately, deeply, and sustainably impacted in Germany and worldwide. The infrastructure of almost all hospitals is currently redirected to provide a maximum of intensive care resources, including the necessary staff. In parallel, routine as well as emergency clinical care for all patients in need has to be secured. This challenge becomes particularly evident in cancer care. In order to maintain adequate oncological care at all levels of provision and to conduct especially curative and intensive treatments with a maximum of safety, continuous adaption of the oncology care system has to be ensured. Intensive communication with colleagues and patients is needed as is consequent expert networking and continuous reflection of the own developed strategies. In parallel, it is of high importance to actively avoid cessation of innovation in order not to endanger the continuous improvement in prognosis of cancer patients. This includes sustained conduction of clinical trials as well as ongoing translational research. Here, we describe measures taken at the University Cancer Center Hamburg (UCCH) - a recognized comprehensive oncology center of excellence - during the COVID-19 crisis. We aim to provide support and potential perspectives to generate a discussion basis on how to maintain high-end cancer care during such a crisis and how to conduct patients safely into the future."],"journal":"Oncol Res Treat","authors":["Weisel, Katja C","Morgner-Miehlke, Andrea","Petersen, Cordula","Fiedler, Walter","Block, Andreas","Schafhausen, Philippe","Knobloch, Johannes K","Bokemeyer, Carsten"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380501","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1159/000508272","keywords":["covid-19","cancer care","sars-cov-2"],"locations":["Germany"],"countries":["Germany"],"countries_codes":["DEU|Germany"],"topics":["Prevention"],"weight":1,"_version_":1666262687561023488,"score":67.0662},{"pmid":32434108,"title":"Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!","text":["Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!","At the end of January 2020, a novel betacoronavirus, known as severe acute respiratory syndrome coronavirus 2, progressively spread in Italy. Patients with cancer are considered more prone to infections because of the immunosuppressive status due to both malignancy and anticancer treatments. From the first Italian government restrictions (23rd February), Modena Cancer Center adopted practical health vigilance recommendations to minimise the risk of exposure to the virus without overlooking cancer management. From 23rd February to 31st March 2020, 1257 patients on active anticancer treatment for oncological or haematological malignancies attended our institution. All the staff activities were rescheduled following our practical coronavirus disease 2019 (COVID-19) guideline. During this period, we have tallied 9 cases of COVID-19 infection (0.71%) in patients with cancer and 3 cases (1.66%) in health workers. The mortality rate of our patients with cancer was 22%, consistent with the data reported in the literature. In conclusion, following our practical health vigilance recommendations, physicians should be confident in maintaining life-saving anticancer treatment without exceedingly increasing the risk of nosocomial COVID-19 infection. The high rate of mortality suggested that all patients on active anticancer treatment with flu-like symptoms have to be carefully screened for COVID-19 infection.","Eur J Cancer","Omarini, Claudia","Maur, Michela","Luppi, Gabriele","Narni, Franco","Luppi, Mario","Dominici, Massimo","Longo, Giuseppe","Piacentini, Federico","32434108"],"abstract":["At the end of January 2020, a novel betacoronavirus, known as severe acute respiratory syndrome coronavirus 2, progressively spread in Italy. Patients with cancer are considered more prone to infections because of the immunosuppressive status due to both malignancy and anticancer treatments. From the first Italian government restrictions (23rd February), Modena Cancer Center adopted practical health vigilance recommendations to minimise the risk of exposure to the virus without overlooking cancer management. From 23rd February to 31st March 2020, 1257 patients on active anticancer treatment for oncological or haematological malignancies attended our institution. All the staff activities were rescheduled following our practical coronavirus disease 2019 (COVID-19) guideline. During this period, we have tallied 9 cases of COVID-19 infection (0.71%) in patients with cancer and 3 cases (1.66%) in health workers. The mortality rate of our patients with cancer was 22%, consistent with the data reported in the literature. In conclusion, following our practical health vigilance recommendations, physicians should be confident in maintaining life-saving anticancer treatment without exceedingly increasing the risk of nosocomial COVID-19 infection. The high rate of mortality suggested that all patients on active anticancer treatment with flu-like symptoms have to be carefully screened for COVID-19 infection."],"journal":"Eur J Cancer","authors":["Omarini, Claudia","Maur, Michela","Luppi, Gabriele","Narni, Franco","Luppi, Mario","Dominici, Massimo","Longo, Giuseppe","Piacentini, Federico"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32434108","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ejca.2020.04.034","keywords":["covid-19","cancer care","pandemic","practical health vigilance recommendations","sars-cov-2"],"locations":["Italy","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667342288171302913,"score":66.31064},{"pmid":32346393,"pmcid":"PMC7176065","title":"COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study.","text":["COVID-19 and its ramifications for cancer patients in low-resource settings: Ghana as a case study.","The impact of COVID-19 on healthcare in low- and middle-income countries (LMICs) is a major challenge requiring urgent measures. Cancer care in LMICs, including Ghana, is faced with inadequate numbers of skilled healthcare professionals and essential material resources which negatively impacts the quality of healthcare and wellbeing of patients. In the face of COVID-19, cancer patients are likely to be affected in three key ways: access to healthcare, increased financial toxicity and increased mental health burden as a consequence of strict measures being implemented to contain the virus in Ghana, including partial lockdowns and social distancing. Some cultural beliefs regarding COVID-19 and its influence on the health and wellbeing of cancer patients have also been discussed. Measures by the government to lessen the burden on citizens and health workers are highlighted with possible recommendations for improvement in cancer care in Ghana and other LMICs during this pandemic.","Ecancermedicalscience","Kugbey, Nuworza","Ohene-Oti, Naomi","Vanderpuye, Verna","32346393"],"abstract":["The impact of COVID-19 on healthcare in low- and middle-income countries (LMICs) is a major challenge requiring urgent measures. Cancer care in LMICs, including Ghana, is faced with inadequate numbers of skilled healthcare professionals and essential material resources which negatively impacts the quality of healthcare and wellbeing of patients. In the face of COVID-19, cancer patients are likely to be affected in three key ways: access to healthcare, increased financial toxicity and increased mental health burden as a consequence of strict measures being implemented to contain the virus in Ghana, including partial lockdowns and social distancing. Some cultural beliefs regarding COVID-19 and its influence on the health and wellbeing of cancer patients have also been discussed. Measures by the government to lessen the burden on citizens and health workers are highlighted with possible recommendations for improvement in cancer care in Ghana and other LMICs during this pandemic."],"journal":"Ecancermedicalscience","authors":["Kugbey, Nuworza","Ohene-Oti, Naomi","Vanderpuye, Verna"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346393","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3332/ecancer.2020.ed99","keywords":["covid-19","ghana","access to care","cancer care","financial toxicity","mental health"],"locations":["Ghana","Ghana","Ghana","Ghana"],"countries":["Ghana"],"countries_codes":["GHA|Ghana"],"topics":["Prevention"],"weight":1,"_version_":1666138495431737344,"score":65.04125},{"pmid":32298036,"title":"Framework for prioritizing head and neck surgery during the COVID-19 pandemic.","text":["Framework for prioritizing head and neck surgery during the COVID-19 pandemic.","The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing.","Head Neck","Topf, Michael C","Shenson, Jared A","Holsinger, F Christopher","Wald, Samuel H","Cianfichi, Lisa J","Rosenthal, Eben L","Sunwoo, John B","32298036"],"abstract":["The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing."],"journal":"Head Neck","authors":["Topf, Michael C","Shenson, Jared A","Holsinger, F Christopher","Wald, Samuel H","Cianfichi, Lisa J","Rosenthal, Eben L","Sunwoo, John B"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298036","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/hed.26184","keywords":["covid-19","sars-cov-2","clinical practice guidelines","head and neck cancer","surgical oncology"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138493331439616,"score":63.427402}]}